Methyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate

Catalog No. :
ACGATX564
CAS No. :
90007-75-3
Molecular Formula :
C8H10N2O4
Molecular Weight :
198.18

IUPAC Name:methyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate

Methyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$52.00Login to see priceIn stockInquiry
250mg98%$83.00Login to see priceIn stockInquiry
1g98%$225.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate
IUPAC Namemethyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate
Molecular FormulaC8H10N2O4
Molecular Weight198.18
SMILESO=C(OC)CCN(C(N1)=O)C=CC1=O
InChI KeyWFCIIRXTEXKYTF-UHFFFAOYSA-N
SynonymOTAVA-BB BB7020410011;Methyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate;methyl 3-(2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)propanoate;1(2H)-Pyrimidinepropanoic acid, 3,4-dihydro-2,4-dioxo-, methyl ester
CAS No.90007-75-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACGATX564 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACUFOJ456 route compound structure diagram
    ACUFOJ4562950-82-5 In Stock
  4. Then
  5. ACGATX564 route product structure diagram
    ACGATX56490007-75-3 In Stock
Inquiry

2. ACGATX564 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGATX564 route product structure diagram
    ACGATX56490007-75-3 In Stock
Inquiry

Comments (0)